COVID-19 VIRUS IN OUR SIGHTS
March 25, 2020
Steven I. Marlowe MD FACP FIDSA Medical Director, Molecular Diagnostics. Dear Family and Friends — We’re learning more and more about this epidemic as it progresses,
* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 10,000 tests per day.
Total Reported: 1,200,000+
Turnaround
0.5 Days
Steven I. Marlowe MD FACP FIDSA Medical Director, Molecular Diagnostics. Dear Family and Friends — We’re learning more and more about this epidemic as it progresses,
Willoughby Mariano, J. Scott Trubey, The Atlanta Journal-Constitution ‘What this highlights is that the system is broken,’ says one lab exec. These are some of
Dear Colleagues, Ipsum Diagnostics is pleased to announce that we will start testing specimens for the virus that causes COVID-19. Please go to the COV-19
Nobel Laureate and Stanford Professor Michael Levitt unexpectedly became a reassuring figure in China at the peak of the coronavirus pandemic. Now he assures Israelis:
Ipsum Diagnostics is one of the first local, privately held, independent diagnostic labs to be testing for coronavirus in Atlanta, GA. We want to provide
8607 Roberts Drive
Suite 250
Atlanta, GA 30350
Phone: 678-915-2299
Fax: 844-364-8451
info@ipsumdiagnostics.com
Hours: Mon – Fri: 8am – 6pm
CAP No. 857023601 CLIA No. 11D2125186
Copyright © 2021 Ipsum Diagnostics. All Rights Reserved.